Karyopherin 13 Activators, part of the karyopherin protein family, are vital regulators involved in the transportation of molecules across the nuclear membrane, facilitating the movement of proteins between the cytoplasm and the nucleus. These activators are specifically linked to the modulation of Karyopherin 13 (KPNA13), a member of the importin-β family, which plays a fundamental role in the nucleocytoplasmic transport of macromolecules. The primary function of Karyopherin 13 Activators is to regulate the activity and specificity of KPNA13, thereby exerting control over the transportation of cargo proteins into the nucleus. KPNA13 functions as an adaptor molecule that binds to the cargo proteins and interacts with the nuclear pore complex, enabling the translocation of these cargoes across the nuclear envelope. Karyopherin 13 Activators modulate this process by regulating the binding affinity of KPNA13 to its cargo proteins, thereby influencing their transportation dynamics.
The activation of KPNA13 mediated by Karyopherin 13 Activators involves intricate molecular interactions, including conformational changes and structural rearrangements that modulate the affinity of KPNA13 for its cargo molecules. This modulation ensures the precise and selective translocation of specific proteins, such as transcription factors and other regulatory proteins, into the nucleus, contributing significantly to the regulation of essential cellular processes like gene expression, signal transduction, and cell cycle progression. Karyopherin 13 Activators, through their regulatory role in nucleocytoplasmic transport mediated by KPNA13, orchestrate the spatial and temporal dynamics of protein localization within the cell, influencing the intricate network of cellular activities essential for proper cellular function and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that can affect nuclear-cytoplasmic transport. It may indirectly modulate KPNA4 activity by altering intracellular calcium levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Etoposide induces DNA damage, which can affect nuclear-cytoplasmic transport indirectly, potentially influencing KPNA4 activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is a histone deacetylase inhibitor that can affect chromatin structure and nuclear-cytoplasmic transport, potentially influencing KPNA4 activity. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone can modulate gene expression and nuclear-cytoplasmic transport, potentially influencing KPNA4 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, raising intracellular cAMP levels and potentially affecting nuclear-cytoplasmic transport, potentially influencing KPNA4 activity. | ||||||